Quantification of seven novel synthetic opioids in blood using LC–MS/MS
The objective of this study was to develop, optimize, and validate a method for the simultaneous quantification of U-47700, AH-7921, U-49900, U-50488, MT-45, W-18, and W-15 in whole blood using liquid chromatography–tandem mass spectrometry (LC–MS/MS).
Blood samples (500 µL) were fortified with mixed calibrator or quality control (25 µL) and internal standard (10 µL) solutions. Analytes were isolated via a solid-phase extraction procedure. Analysis was performed using an Agilent 1290 Infinity II liquid chromatograph coupled to an Agilent 6470 triple quadrupole mass spectrometer. The method was validated in accordance with Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology and applied to the analysis of postmortem blood specimens.
Lower limits of quantification were 0.25–1 ng/mL and the upper limits of quantification were 100 ng/mL. The coefficients of determination (R2) for the calibration curves were > 0.99. Analytical bias, within-run imprecision, and between-run imprecision were within ± 15%, ≤ 16%, and ≤ 17%, respectively. All analytes were found to be stable at room temperature for 24 h, refrigerated (4 °C) for 72 h, and in the autosampler (4 °C) for 72 h. Authentic blood samples (n = 30) were analyzed using the validated method. Mean (range) U-47700 concentrations were 214 (3.2–1448) ng/mL in 15 cases.
A quantification method for seven synthetic opioids (U-47700, AH-7921, U-49900, U-50488, MT-45, W-18, and W-15) in whole blood was developed, optimized, and validated in accordance with SWGTOX standard practices for method validation in forensic toxicology. This sensitive method was successfully applied to postmortem casework.
KeywordsNovel synthetic opioids U-47700 W-18 W-15 Method validation LC – MS/MS
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
This article does not contain any studies with animals performed by any of the authors. The blank blood samples were acquired by healthy volunteers after obtaining informed consent.
- 3.Coopman V, Blanckaert P, Van Parys G, Van Calenbergh S, Cordonnier J (2016) A case of acute intoxication due to combined use of fentanyl and 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700). Forensic Sci Int 266:68–72. https://doi.org/10.1016/j.forsciint.2016.05.001 CrossRefGoogle Scholar
- 5.Dosaka-Akita K, Tortella FC, Holaday JW, Long JB (1993) The kappa opioid agonist U-50,488 H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats. J Pharmacol Exp Ther 264:631–637Google Scholar
- 22.Morrow JB, Ropero-Miller JD, Catlin ML, Winokur AD, Cadwallader AB, Staymates JL, Williams SR, McGrath JG, Logan BK, McCormick MM, Nolte KB, Gilson TP, Menendez MJ, Goldberger BA (2018) The opioid epidemic: moving toward an integrated, holistic analytical response. J Anal Toxicol. https://doi.org/10.1093/jat/bky049
- 27.Truver MT, Swortwood MJ (2018) Quantitative analysis of novel synthetic opioids, morphine and buprenorphine in oral fluid by LC–MS–MS. J Anal Toxicol. https://doi.org/10.1093/jat/bky053
- 28.Zaney ME, Shoff EN, Hime GW, Boland DM (2017) Detection of U-47700 in blood and drug paraphernalia from postmortem cases. Society of Forensic Toxicologists Annual Meeting, Boca RatonGoogle Scholar
- 29.Hartman RL, Salamone ME, Nemeth DJ, Gallagher TM, Fellows JS, Kadlec LM, Beno JM (2017) Furanyl fentanyl, butyryl fentanyl, and U-47700 in blood and urine of drivers arrested for driving under the influence of drugs (DUID). Society of Forensic Toxicologists Annual Meeting, Boca RatonGoogle Scholar